Arkolith/Insider Trading/XFOR/Form 4

Craig Adam R

Executive Chairman, DirectorX4 Pharmaceuticals, Inc (XFOR) · full profile →Form 4 · filed Oct 31, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 29, 2025Grant(A)2.3M—$02.3M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001339498-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML